Publications by authors named "Alan W Carter"

Claim this Profile
I
Intercepting a Mycobacterial Biosynthetic Pathway with Covalent Labeling.
Theodore C Warner, Victoria M Marando, Omar A Santiago-Reyes, Elizabeth M Hart, Stephanie R Smelyansky, Alan W Carter

J Am Chem Soc· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Squarates as Amine-Reactive Probes.
Katherine I Taylor, Jordan S Ho, Hallie O Trial, Alan W Carter, Laura L Kiessling

J Am Chem Soc· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Response to Letters to the Editor From the American Diabetes Association and Eli Lilly in Regard to: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain.
Alan W Carter, Lutz Heinemann

J Diabetes Sci Technol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain.
Alan W Carter, Lutz Heinemann

J Diabetes Sci Technol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will Biosimilar Insulins Be Cheaper?
Lutz Heinemann, Alan W Carter

Diabetes Technol Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
If PBMs Guard Access to Drugs, Then Quis Custodiet Ipsos Custodies? (Who Will Guard the Guardians?).
Alan W Carter, Lutz Heinemann

J Diabetes Sci Technol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In the Biosimilar Marketplace Will There Be 50 Ways to Leave Your Insulin?
Alan W Carter

J Diabetes Sci Technol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality Control of Insulins and Biosimilar Insulins: What Do We Know?
Alan W Carter, Lutz Heinemann, David C Klonoff,

J Diabetes Sci Technol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA-approved biosimilar insulin: good enough for critical care, adulterated, or counterfeit? How can we tell?
Alan W Carter

J Diabetes Sci Technol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the injection force of solostar® compared with other disposable insulin pen devices at constant volume flow rates.
Alan W Carter

J Diabetes Sci Technol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of the assessment of glycated hemoglobin using A1cNow+ point-of-care device compared to central laboratory testing--an important addition to pharmacist-managed diabetes programs?
Alan W Carter

J Diabetes Sci Technol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care.
Cameron C Lindsey, Alan W Carter, Stacy Mangum, Dorothy Greene, Antoine Richardson

Diabetes Technol Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized, multicentered controlled trial to compare the annual outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care: a 3-month interim analysis.
Cameron C Lindsey, Alan W Carter, Stacy Mangum, Dorothy Greene, Antoine Richardson

Diabetes Technol Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home fructosamine testing: is its demise premature?
Alan W Carter

Diabetes Technol Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis